b.brandt
TL2 · Bursa
Contributes reviews on supplier material. Based in Bursa.
Joined 2 February 2025 · last posted 2d
85 posts, newest first. Showing up to 150.
-
How shortages have affected compounding permissions Replied, post #72 · Access › Shortages · 26 Jul 2026 · 9 likes On shortages I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads get…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #49 · Clinical › Prescriber conversations · 25 Jul 2026 · 13 likes A pharmacist can answer a great many of the questions people save for a prescriber, faster and often better, particularly about interactions and formulations. It is the…
-
Documenting a supplier's response to a discrepancy Replied, post #34 · Sourcing › Vendor reports · 9 Jul 2026 · 7 likes Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence. That much is documented. The rest is how I have…
-
Request: a per-category review queue Replied, post #75 · Meta › Feature requests · 2 Jul 2026 · 1 like Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete. I would hold that lightly until someone with a larger…
-
Retatrutide mass and identity: what a report should show Replied, post #8 · Compounds › Retatrutide · 2 Jul 2026 · 1 like Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
-
How shortages have affected compounding permissions Replied, post #9 · Access › Shortages · 1 Jul 2026 · 6 likes I have been on both sides of the shortages argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #48 · Compounds › Oral incretins · 18 Jun 2026 · 28 likes Post #47 answers the question as asked. The question underneath it is different. Research-use-only oral material is not a licensed tablet and there is no reason to…
-
Bioimpedance and hydration: why the number moves Replied, post #62 · Outcomes › Body composition · 18 Jun 2026 · 18 likes The arithmetic in post #60 is right; the assumption feeding it is the part to check. Neither method is capable of detecting the month-to-month changes that people…
-
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #4 · Practice › Side effects · 10 Jun 2026 · 0 likes The opening post is the version of this I will quote in future. One addition. I disagree with the framing of Taste changes and food aversion above, and I think it is a…
-
Official shortage notices and what they authorise Replied, post #96 · Access › Shortages · 9 Jun 2026 · 3 likes Narrowing post #93, because the general version has more than one answer. Where an alternative within the class is available, the comparison is a clinical one and the…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #5 · Access › International · 8 Jun 2026 · 0 likes Everything in the opening post holds. The case it does not cover is the one I have. Travel with medication: carrying a compound across borders is complicated by legal…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #92 · Sourcing › Red flags · 6 Jun 2026 · 1 like Coming back to post #88, because the follow-up matters more than the original answer. Where somebody posts a concern, ask what would resolve it before arguing about it.…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #38 · Analytics › Impurities & related substances · 6 Jun 2026 · 3 likes Offering a way to settle Endotoxin rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the noise,…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #30 · Practice › Storage & stability · 3 Jun 2026 · 0 likes Where I part company with post #28, and it is a narrow parting. I would call the community position on reconstituted likely rather than established, and I would be…
-
Bariatric surgery history: altered anatomy, altered expectations Replied, post #18 · Clinical › Special populations · 21 May 2026 · 1 like I will take the caveat as seriously as the claim, which is the point of putting it there.
-
How this community labels and discusses unrefereed work — the long version Replied, post #4 · Evidence › Preprints · 10 May 2026 · 21 likes The most useful convention this subcategory has: state the status, state the version, state the date you checked. Three short clauses and the citation stays honest.
-
Prescription portability between countries Replied, post #23 · Access › International · 4 May 2026 · 0 likes Answering the question post #19 raises rather than the one it answers. I have been on both sides of the prescription portability between countries argument in this…
-
Request: show the solution author in the topic list — what changed since Replied, post #49 · Meta › Feature requests · 2 May 2026 · 7 likes Post #46 put the caveat in the right place and I want to underline it. Counter-request, gently: please do not add anything on hover. It does not exist on a phone and…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #97 · Compounds › Tirzepatide · 25 Apr 2026 · 1 like Post #94 is the version of this I will quote in future. One addition. Where I would push back on the 2.5 mg starting dose consensus is the confidence, not the…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #34 · Analytics › HPLC & UHPLC · 23 Apr 2026 · 0 likes Carryover from a previous injection shows up as a small peak at the same retention time in a blank. A method report that includes a blank injection is telling you the…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #6 · Compounds › Semaglutide · 22 Apr 2026 · 3 likes On post #2 — agreed on the reasoning, with one qualification. Albumin binding is not a unique structural feature and nothing in the class lacks it, but the…
-
Deletion sequences: expected mass shifts by residue Replied, post #2 · Analytics › Impurities & related substances · 13 Apr 2026 · 9 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #11 · Analytics › HPLC & UHPLC · 10 Apr 2026 · 9 likes Building on post #8 rather than restating it. On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with…
-
CJC-1295 with and without DAC: what the modification does Replied, post #25 · Compounds › Secretagogues & GH axis · 2 Apr 2026 · 0 likes Checked the CJC-1295 claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
-
What other technical communities get right that we do not Replied, post #2 · Lounge › Off topic · 25 Mar 2026 · 22 likes Not a rules-free zone: the guidelines still apply. No contact details, no invitations to take a conversation off the site, no endorsements of other communities. Just a…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #74 · Analytics › Mass spectrometry · 19 Mar 2026 · 28 likes The arithmetic in post #73 is right; the assumption feeding it is the part to check. A definition problem is doing most of the work in this Adducts discussion. Once the…
-
Oral versus injected administration claims for BPC-157 Replied, post #13 · Compounds › Repair & healing peptides · 13 Mar 2026 · 20 likes Offering a way to settle oral versus injected administration claims rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If…
-
Splitting a weekly dose in two: the pharmacokinetic argument against Replied, post #21 · Practice › Dosing & titration · 10 Mar 2026 · 0 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #116 · Evidence › Study critique · 6 Mar 2026 · 0 likes Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #22 · Outcomes › Body composition · 6 Mar 2026 · 0 likes Ultrasound and skinfolds came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #31 · Practice › Storage & stability · 6 Mar 2026 · 8 likes Answering the peptide question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first…
-
Micro-titration: a disputed topic, argued properly Replied, post #42 · Practice › Dosing & titration · 5 Mar 2026 · 10 likes The reason micro-titration keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #34 · Evidence › Trials · 11 Feb 2026 · 6 likes This is the sort of exchange that makes the archive worth searching.
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #66 · Clinical › Bloodwork · 2 Feb 2026 · 2 likes Everything in post #62 holds. The case it does not cover is the one I have. Lipid changes during substantial weight loss are expected and their trajectory is not always…
-
Coverage in the US: a map of the usual obstacles Replied, post #40 · Regional › North America · 23 Jan 2026 · 0 likes The public assessment documents published at approval are free, detailed and largely unread here. That has held every time I have looked, which is not the same as always.
-
Filter needles: when they help and what they cost you Replied, post #32 · Devices › Syringes & needles · 22 Jan 2026 · 0 likes The arithmetic in post #29 is right; the assumption feeding it is the part to check. U-100 means the barrel is graduated for a solution containing one hundred units of…
-
Liver enzymes drifting down and what that usually means Replied, post #46 · Clinical › Bloodwork · 14 Jan 2026 · 23 likes Summarising the liver enzymes drifting thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it,…
-
A partial dose because the pen emptied mid-injection Replied, post #5 · Practice › Administration · 6 Jan 2026 · 3 likes Air in the syringe is a much smaller problem subcutaneously than the anxiety about it suggests, and it is still worth expelling because the bubble occupies volume you…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #36 · Practice › Storage & stability · 15 Dec 2025 · 1 like Marking my uncertainty on Storing lyophilised material long term explicitly. I am confident about the direction, much less confident about the size, and not confident…
-
The decimal-point error, and the habit that catches it Replied, post #24 · Practice › Reconstitution · 14 Dec 2025 · 17 likes Post #21 is right about the mechanism and I think understates the practical bit. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and…
-
Second pass at: Programming during a large energy deficit Replied, post #79 · Nutrition & Training › Resistance training · 13 Nov 2025 · 8 likes Coming back to post #77, because the follow-up matters more than the original answer. My experience of Programming during a large energy contradicts the reply above. I…
-
Conference abstracts as evidence: the weakest common citation Replied, post #5 · Evidence › Preprints · 29 Oct 2025 · 0 likes Building on post #3 rather than restating it. Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #66 · Compounds › Tirzepatide · 22 Oct 2025 · 8 likes Answering the SURMOUNT-4 question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first…
-
Pooling trials with different estimands — what changed since Replied, post #39 · Evidence › Meta-analyses · 19 Oct 2025 · 7 likes Post #38 answers the question as asked. The question underneath it is different. Subgroup meta-analysis multiplies the usual subgroup problems by the number of included…
-
A 40-week log with the measurement method stated Replied, post #30 · Outcomes › Progress reports · 18 Oct 2025 · 3 likes A note on scope: what I am saying about 40-week log applies to the case in the first post and I would not extend it further without checking.
-
Titles that describe the question, not the situation Replied, post #120 · Start Here › How to Ask · 13 Oct 2025 · 33 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #17 · Compounds › Cagrilintide & amylin analogues · 1 Oct 2025 · 0 likes Understood, and I withdraw the assumption I opened with.
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #54 · Evidence › Preprints · 30 Sep 2025 · 0 likes The honest position on most preprints in this field is that they are interesting and provisional, and that saying both is not fence-sitting. The uncertainty is in the…
-
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #34 · Analytics › Mass spectrometry · 6 Sep 2025 · 16 likes Post #32 and I disagree about the size of the effect, not about the direction. Deamidation adds approximately one dalton and produces a species that frequently elutes…
-
Revisiting: Why I ask for the gradient before I discuss the number Replied, post #17 · Analytics › HPLC & UHPLC · 2 Sep 2025 · 0 likes A chromatogram image at a resolution where you can see peak shape but not baseline detail is worth having and is not the same as the data. Ask for the integration table…
-
Hypertension improvement and when medication needs revisiting Replied, post #26 · Clinical › Comorbidities · 26 Aug 2025 · 16 likes The practical value of this subcategory is helping somebody frame the question they take to an appointment, and that is worth being explicit about. Written in the hope…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #46 · Compounds › Semaglutide · 22 Aug 2025 · 1 like Answering the question post #45 raises rather than the one it answers. Appetite effects and gastrointestinal effects are frequently reported together and are not the…
-
When a preprint is the best available evidence and we say so Replied, post #76 · Evidence › Preprints · 20 Aug 2025 · 2 likes Narrowing post #75, because the general version has more than one answer. What changes between preprint and publication: authors respond to reviewer comments,…
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #23 · Evidence › Preprints · 18 Aug 2025 · 11 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Sequence verification for an obscure compound: how it is done Replied, post #95 · Compounds › Other compounds · 17 Jul 2025 · 0 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
-
A field-by-field walk through a certificate of analysis Replied, post #89 · Analytics › COA interpretation · 17 Jul 2025 · 0 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #125 · Compounds › Tirzepatide · 1 Jul 2025 · 14 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
Second pass at: Semaglutide and alcohol: what is actually documented Replied, post #17 · Compounds › Semaglutide · 22 Jun 2025 · 18 likes Trying to state the Semaglutide and alcohol position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread…
-
Half-life, steady state, and accumulation worked through Replied, post #112 · Pharmacology › Pharmacokinetics · 13 Jun 2025 · 21 likes Picking up post #109: that is the part I would want checked first. Accumulation at steady state: with a week-long half-life, steady-state concentration is reached…
-
Reading a chromatogram someone posted without axes Replied, post #35 · Analytics › HPLC & UHPLC · 20 May 2025 · 13 likes This follows post #34 rather than contradicting it. The most useful thing anyone has posted about reading a chromatogram in this category was a table of what had been…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #90 · Clinical › Comorbidities · 20 May 2025 · 13 likes I read post #88 twice before replying, because I had assumed the opposite. I have been on both sides of the obstructive sleep apnoea argument in this category within…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #73 · Analytics › Mass spectrometry · 20 Apr 2025 · 0 likes The arithmetic in post #72 is right; the assumption feeding it is the part to check. The most useful reply I ever got about adducts was a request to state my units. It…
-
EU-wide position versus national implementation Started this topic · Regional › European Union · 17 Apr 2025 · 36 likes EU-wide position versus national implementation Writing it up because I had to work it out twice and would rather nobody else did. Eu-wide position versus national…
-
Antibiotics and a course of something with delayed emptying Replied, post #14 · Practice › Interactions · 3 Apr 2025 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #34 · Sourcing › Vendor reports · 29 Mar 2025 · 0 likes Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows which supplier it came from until the result is back.…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #20 · Practice › Interactions · 20 Mar 2025 · 10 likes This follows post #19 rather than contradicting it. The version of delayed gastric emptying and oral that circulates here is a simplification of a simplification. It is…
-
Maintainer handover: how it works Replied, post #68 · Meta › Wiki maintenance · 18 Mar 2025 · 21 likes Post #66 and I disagree about the size of the effect, not about the direction. I have three months of notes on maintainer handover and the honest summary is that the…
-
A promotion I argued against, and why I lost Replied, post #136 · Documentation › Doc review · 17 Mar 2025 · 31 likes The most useful review comment names a sentence and says what is wrong with it. General approval and general concern are both hard to act on. Adding it in case it saves…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #35 · Evidence › Journal club · 1 Feb 2025 · 6 likes Worth separating SUSTAIN 6 as a question about the compound from SUSTAIN 6 as a question about the documentation. They get answered by different people and only one of…
-
Distinguishing a deletion sequence by mass alone Replied, post #23 · Analytics › Mass spectrometry · 27 Jan 2025 · 32 likes Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the commonest overclaim in this subcategory.…
-
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #24 · Practice › Dosing & titration · 6 Jan 2025 · 17 likes Confirming post #23 from a second method, which matters more than confirming it from a second person. A methods point on Holding a dose rather than a substantive one:…
-
Books and papers worth reading that are not about this at all Replied, post #6 · Lounge › Off topic · 1 Jan 2025 · 2 likes Loosely related and not worth its own topic: the vocabulary here has leaked into how I read everything. I now notice when a press release gives a relative figure and no…
-
What a seizure notice actually says Replied, post #20 · Sourcing › Logistics · 31 Dec 2024 · 27 likes Seizure notice has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #71 · Compounds › Semaglutide · 26 Dec 2024 · 1 like Coming back to post #67, because the follow-up matters more than the original answer. An update on my earlier Semaglutide half-life post: the pattern held for another…
-
Second pass at: Regression to the mean in progress reports Replied, post #8 · Research Methods › Statistics · 25 Dec 2024 · 2 likes The honest answer on Regression is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter. Most…
-
Coming back to: Renal impairment: what the labelling says about dose Replied, post #24 · Clinical › Special populations · 25 Dec 2024 · 0 likes Taking post #23 at face value and following it one step further. Nobody has said the unglamorous part of Renal impairment yet, so: most of the variation is explained by…
-
Follow-up: Oral contraceptives and delayed emptying: what the data shows Replied, post #32 · Practice › Interactions · 23 Dec 2024 · 0 likes Post #28 describes the usual case. This is about the unusual one. The practical advice most consistently given by pharmacists here is to keep the timing of other oral…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #72 · Compounds › Repair & healing peptides · 16 Nov 2024 · 16 likes Confirming post #69 from a second method, which matters more than confirming it from a second person. Adding a reference point for reading a preclinical wound-healing…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #6 · Practice › Side effects · 15 Nov 2024 · 0 likes Taking post #5 at face value and following it one step further. Practical experience of injection-site reactions, offered as one case with the conditions stated, not as…
-
People with a low starting BMI: where the evidence stops Replied, post #7 · Clinical › Special populations · 12 Oct 2024 · 6 likes Being outside the studied population does not mean a treatment is unsafe. It means the usual evidence is not available and the reasoning has to be explicit.
-
Coming back to: Prediction intervals and why they are more honest than confidence… Replied, post #3 · Evidence › Meta-analyses · 11 Oct 2024 · 15 likes The opening post describes the usual case. This is about the unusual one. A tighter confidence interval around a meaningless centre is worse than a wide interval around…
-
Progressive overload when the scale is falling — one year on Replied, post #81 · Nutrition & Training › Resistance training · 22 Sep 2024 · 4 likes Filing a mild objection to the consensus on Progressive overload. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
-
Correlation in a self-tracked dataset: what it can support Replied, post #10 · Research Methods › Statistics · 20 Aug 2024 · 1 like Small methodological point on correlation: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
-
Transit times by route, from a logged dataset — the long version Replied, post #4 · Sourcing › Logistics · 8 Aug 2024 · 24 likes The version of Transit times that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
How this community labels and discusses unrefereed work Replied, post #113 · Evidence › Preprints · 26 Jul 2024 · 0 likes Summarising the community labels thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the…